Paragon Capital Management (Colorado)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
1,409
-19
-1% -$19.3K 0.27% 38
2025
Q4
$1.54M Buy
1,428
+1
+0.1% +$956 0.31% 33
2025
Q3
$1.09M Buy
1,427
+2
+0.1% +$1.49K 0.2% 47
2025
Q2
$1.11M Buy
1,425
+2
+0.1% +$1.55K 0.2% 47
2025
Q1
$1.18M Buy
1,423
+1
+0.1% +$832 0.24% 41
2024
Q4
$1.1M Buy
1,422
+1
+0.1% +$828 0.22% 40
2024
Q3
$1.26M Buy
1,421
+2
+0.1% +$1.8K 0.25% 37
2024
Q2
$1.29M Buy
1,419
+19
+1% +$15.2K 0.24% 35
2024
Q1
$1.09M Sell
1,400
-25
-2% -$17.8K 0.19% 40
2023
Q4
$831K Sell
1,425
-160
-10% -$93.4K 0.17% 44
2023
Q3
$851K Buy
1,585
+20
+1% +$10.3K 0.19% 42
2023
Q2
$734K Buy
1,565
+1
+0.1% +$419 0.16% 48
2023
Q1
$537K Buy
1,564
+2
+0.1% +$675 0.12% 64
2022
Q4
$572K Sell
1,562
-53
-3% -$18.8K 0.15% 56
2022
Q3
$522K Buy
1,615
+2
+0.1% +$634 0.15% 52
2022
Q2
$523K Buy
1,613
+2
+0.1% +$600 0.15% 49
2022
Q1
$461K Buy
1,611
+3
+0.2% +$772 0.09% 72
2021
Q4
$444K Sell
1,608
-16
-1% -$4.06K 0.07% 70
2021
Q3
$375K Buy
1,624
+2
+0.1% +$494 0.06% 79
2021
Q2
$372K Buy
1,622
+3
+0.2% +$603 0.17% 62
2021
Q1
$303K Buy
1,619
+2
+0.1% +$391 0.16% 72
2020
Q4
$273K Buy
1,617
+3
+0.2% +$448 0.15% 74
2020
Q3
$239K Sell
1,614
-96
-6% -$14.9K 0.13% 76
2020
Q2
$281K Buy
1,710
+3
+0.2% +$460 0.12% 65
2020
Q1
$237K Buy
1,707
+3
+0.2% +$412 0.13% 58
2019
Q4
$224K Buy
+1,704
New +$198K 0.12% 161
2019
Q2
Sell
-1,693
Closed -$220K 171
2019
Q1
$220K Buy
+1,693
New +$206K 0.13% 163
2018
Q4
Sell
-1,888
Closed -$203K 230
2018
Q3
$203K Buy
+1,888
New +$189K 0.17% 197
2015
Q4
Sell
-4,736
Closed -$396K 84
2015
Q3
$396K Sell
4,736
-296
-6% -$25K 0.24% 46
2015
Q2
$420K Buy
5,032
+3
+0.1% +$229 0.26% 46
2015
Q1
$365K Buy
+5,029
New +$358K 0.24% 49
2014
Q4
Sell
-5,012
Closed -$325K 72
2014
Q3
$325K Sell
5,012
-195
-4% -$12.3K 0.23% 48
2014
Q2
$324K Buy
5,207
+78
+2% +$4.65K 0.22% 48
2014
Q1
$302K Sell
5,129
-1,054
-17% -$58.8K 0.22% 51
2013
Q4
$315K Buy
6,183
+4
+0.1% +$200 0.23% 45
2013
Q3
$311K Buy
6,179
+5
+0.1% +$262 0.24% 47
2013
Q2
$303K Buy
+6,174
New +$336K 0.24% 51

Other funds holding LLY

Paragon Capital Management (Colorado)'s LLY Position: Q1 2026 in Review

Paragon Capital Management (Colorado) reduced its Eli Lilly (LLY) stake by 1.3% in Q1 2026, selling an estimated $19.3K and leaving 1,409 shares worth $1.3M. The position accounts for 0.27% of the portfolio, ranked #38.

Paragon Capital Management (Colorado) first reported a position in LLY in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.54M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Paragon Capital Management (Colorado) held 1,409 shares of Eli Lilly worth $1.3M as of Q1 2026.
  • Paragon Capital Management (Colorado) sold 19 Eli Lilly shares in Q1 2026, an estimated $19.3K.
  • Eli Lilly made up 0.27% of Paragon Capital Management (Colorado)'s portfolio in Q1 2026, its #38 holding.
  • Paragon Capital Management (Colorado) first reported a position in Eli Lilly in Q2 2013 and has held it in 37 quarters since.
  • Paragon Capital Management (Colorado)'s Eli Lilly position peaked at $1.54M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Paragon Capital Management (Colorado)'s 13F filing for Q1 2026, filed 15 Apr 2026.